Dermot P. McGovern, MD, PhD
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
310-423-4100
Fax: 310-423-0146
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
Dermot P. McGovern, MD, PhD
Scheduling
In person visits
Fax: 310-423-0146
Los Angeles
8730 Alden Drive
Ste East 242
Los Angeles, CA
34.0750072 -118.3828082From You
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
Dermot P. McGovern, MD, PhD
Languages
- English,
Gender
Male
Experience
29 Years
Locations
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- IM Gastroenterology
Programs
Cedars-Sinai clinical programs this provider is part of:
4
Research Areas
Dermot McGovern completed his GI fellowship and obtained a PhD in complex disease genetics at the University of Oxford, England before moving to Cedars-Sinai, Los Angeles 11 years ago. Dr McGovern is the Director of Translational Medicine at the F. Widjaja Foundation Imflammatory Bowel and Immunobiology Research Institute at Cedars-Sinai and also directs the Cedars-Sinai Precision Medicine Initiative. He holds the Joshua and Lisa Greer Endowed Chair in IBD Genetics. Dr. McGovern’s clinical interests include the extra-intestinal complications of IBD and also the overlap between IBD and other immune-mediated and metabolic diseases. Dr. McGovern serves on the National Scientific Advisory Committee for the Crohn’s and Colitis Foundation as well as the steering committees of the National and International IBD Genetics Consortia. He also chairs the CCFA local advisory medical committee. Dr. McGovern serves on the editorial board for the IBD Journal. He has been elected a member of the American Society for Clinical Investigation (ASCI) and also the International Organization for the Study of IBD (IOIBD). Dr. McGovern’s group is funded by the NIH to study the effect of genetics on the susceptibility to and natural history of IBD in diverse populations. Dr McGovern’s group analyze multi’-omic’ datasets to identify potential biomarkers and therapeutic targets of IBD that ‘feed’ the Drug Development Unit he co-directs. His group also have a significant interest in the pharmacogenetics of therapies used in IBD. Extending these studies to diverse populations including African-Americans, Hispanics, and the Ashkenazi Jewish population is a major focus of his group. His group is also funded by the Crohn’s and Colitis Foundation, The Litwin Foundation, and the Helmsley Charitable Trust. Dr. McGovern’s group have published approximately 150 peer-reviewed papers in journals including Nature, Science, Cell, Nature Genetics, The Lancet, and Gastroenterology.
Titles
- Joshua L. and Lisa Z. Greer Chair, Inflammatory Bowel Disease Genetics
- Director, Translational Research in the Inflammatory Bowel and Immunobiology Research Institute
- Professor, Medicine and Biomedical Sciences
Education & Training
-
Oxford Deanery, UK
Fellowship - Completed 2006
-
Oxford Deanery
Degrees - Completed 2005
-
South West Peninsula Deanery
Fellowship - Completed 2000
-
Royal Cornwall Hospital
Fellowship - Completed 1999
-
Gloucestershire Royal Hospital
Residency - Completed 1996
-
Gloucestershire Royal Hospital
Internship - Completed 1994
-
St Mary's Hospital Medical School
Medical School - Completed 1993
Achievements
-
8
Awards and Honors
-
5
Publications
Awards and Honors
- Joshua L. and Lisa Z. Greer Chair, Inflammatory Bowel Disease Genetics
- American Gastroenterology Association
- The Royal College of Physicians of London
- Editorial Board: IBD Journal
- Fellow, The Royal College of Physicians of London
- Editorial Board: Journal of Crohns and Colitis
- EPA Cephalosporin Junior Research Fellowship
- British Society of Gastroenterology
Publications
A full list of this provider’s research publications can be found on their research profile or PubMed.
- A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet. 2014 Sep;46(9):1017-20. doi: 10.1038/ng.3060. PMID: 25108385, PMCID: PMC4999337.
- Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans. Gastroenterology. 2015 Nov;149(6):1575-86. doi: 10.1053/j.gastro.2015.07.065. PMID: 26278503, PMCID: PMC4685036 .
- Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016 Jan 9;387(10014):156-67. doi: 10.1016/S0140-6736(15)00465-1. PMID: 26490195, PMCID: PMC4714968
- Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016 Aug 17;536(7616):285-91. doi: 10.1038/nature19057. PMID: 27535533, PMCID: PMC5018207
- Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012 Nov 1;491(7422):119-24. doi: 10.1038/nature11582. PMID: 23128233, PMCID: PMC3491803 .
